{"id":"W2063677232","doi":"10.1016/j.eururo.2015.09.007","title":"Cardiovascular Safety of β3-adrenoceptor Agonists for the Treatment of Patients with Overactive Bladder Syndrome","year":2015,"lang":"en","type":"review","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Astellas Pharma US; Society for Cultural Anthropology; Pfizer","keywords":"Mirabegron; Medicine; Overactive bladder; Agonist; Urology; Internal medicine; Pharmacology; Intensive care medicine; Receptor; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00348078,0.0004286816,0.002312908,0.002362151,0.0002137773,0.001155144,0.0006697528,0.00138957,0.004763964],"category_scores_gemma":[0.01287505,0.0002272383,0.002943237,0.002588549,0.0003002469,0.0007205839,0.0003908505,0.000923822,0.0004055995],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007784939,"about_ca_system_score_gemma":0.001954889,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001084352,"about_ca_topic_score_gemma":0.00252435,"domain_scores_codex":[0.9972952,0.0009344943,0.000998728,0.0001896204,0.0005235519,0.00005836086],"domain_scores_gemma":[0.9868321,0.008519961,0.003664556,0.00008814612,0.0007910109,0.0001042141],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001546031,0.00005406853,0.003007706,0.6758227,0.01015315,0.0004157569,0.0002160525,0.0002876551,0.001335337,0.0006420935,0.006488234,0.3000311],"study_design_scores_gemma":[0.001613472,0.002993006,0.03001859,0.7505239,0.05683864,0.003800578,0.0007253115,0.0002674966,0.002094567,0.001507395,0.1495005,0.0001167064],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007499794,0.9983256,0.00004106746,0.0003042206,0.00006442932,0.00001480048,0.0001209223,0.00000173511,0.000377232],"genre_scores_gemma":[0.02141891,0.9767878,0.0002915571,0.0008905457,0.000232735,0.00005296343,0.0001922876,0.000002409321,0.0001306725],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004763964,"threshold_uncertainty_score":0.01840836,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05111484413096525,"score_gpt":0.3238697228419654,"score_spread":0.2727548787110001,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}